BIOS — Top 100 TechBio VC Funds 🧬. As TechBio reaches critical mass, we thought it time to centralize the world of TechBio VC into one sheet. We hope this database becomes a useful resource & serves as a go to for founders raising VC Funding….

Landscape #2: Future of Gene Therapy. Gene therapy is more than just a breakthrough for rare monogenic diseases—it's the foundation for a new era in medicine. While current therapies focus on introducing wildtype genes to counteract loss of function mutations, the potential for

Join millions who have switched to Grok.

@BigHatBio @MarkDePristo 🌍 What’s next for @BigHatBio? Discover how they’re building a drug development machine that could revolutionize medicine. Tune in.

@BigHatBio @MarkDePristo Join us as @BigHatBio’s @MarkDePristo & Peyton Greenside discuss how they’re harnessing AI to create better biologics and improve human health. From the origins of BigHat to their cutting-edge platform.

Builders #4 w/ Mark DePristo & Peyton Greenside - Co-Founders @ BigHat Biosciences. 🔍 What sparked the idea behind @BigHatBio? Find out how @MarkDePristo & Peyton combined AI/ML with fast data generation to revolutionize protein therapeutics. This episode is a must-listen for

Imagine a world where we deeply understand cancer, manage our immune systems proactively, and invest in health early. Jennifer Friel Goldstein explores this vision for biotech 2050, where breakthroughs are fueled by novel capital strategies and diverse ecosystems. 🌟.

With women leading health decisions and unmet needs driving innovation, Femtech and digital health are rising fast. Jennifer Friel Goldstein discusses how the future of healthcare lies in inclusive leadership, efficient capital, and breaking down traditional barriers. 🌐💡.

Advancing women's health and diversity in Biotech: Jenniffer Friel Goldman @ SVB Capital. Jennifer Friel Goldstein shares her vision for the future of biotech, where diversity in leadership, capital efficiency, and innovative tools drive a healthcare revolution. From rethinking.

Landscape: Future of Cell Therapy 🧬 . Accelerating gene circuit development in cell therapy! High-throughput tools are revolutionizing design, paving the way for personalized Trx. Explore this perspective & projections on its impact. Read more:

@AlloyTx 🔥 What’s next for Alloy Therapeutics? Get insights from Errik Anderson on the future of biotech and how @AlloyTxis leading the charge in developing breakthrough therapies. Listen in!.

@AlloyTx Discover the science behind @AlloyTx's ATX-Gx platform for antibody discovery and what makes their humanized mice unique. Errik Anderson explains how Alloy is pushing the boundaries of drug discovery. Listen to the full episode! 🧬.

Builders w/ Errik Anderson - Founder & CEO @ Alloy Therapeutics. Ever wondered what it takes to build a 'forever company' in biotech? Errik Anderson shares the genesis of @AlloyTx, detailing how they’re creating a collaborative ecosystem with over 100 partnerships and counting.

@4dmt What does the future hold for biotech? 🤔 David Schaffer envisions a world where advances in gene therapies, synthetic biology, and precision medicine reshape how we treat diseases—from neurodegeneration to cancer. But with this incredible potential comes the need for careful.

@4dmt How does a research culture foster groundbreaking biotech innovation? David Schaffer shares insights from leading QB3, the Schaffer Lab, & more.

Genetic and Cellular Engineering w/ David Schaffer - Prof @ Berkeley. Join us as David Schaffer dives deep into the evolution of AAV delivery systems, the founding story of @4DMT, and the grand challenges in life sciences over the next 20 years. A visionary discussion on the

BIOS Nobel: A Deep Dive into the Life Sciences Through the Eyes of Nobel Prize Recipients. 🌟📜 Get inspired by iconic quotes and deep dives into the discoveries that earned Nobel Prizes in life sciences. Learn more in our new series: Wisdom of the Laureates! 🚀 . Read more:

@NautilusBio The human proteome is a vast, largely uncharted territory in drug discovery. Learn how @NautilusBio's proprietary platform is decoding complex protein interactions to uncover new therapeutic targets, paving the way for next-gen precision medicine.

@NautilusBio 🔮 The Future of Proteomics.What’s next for @NautilusBio and the field of proteomics? Tune in to hear Sujal & Parag’s vision for the future and how it could revolutionize biomedicine.

Builders w/ Sujal Patel & Parag Mallick - Co-Founders @ Nautilus Biotechnology. @NautilusBio co-founders Sujal Patel & Parag Mallick share their journey from the initial spark to going public via a SPAC in 2021. Discover the challenges, triumphs, and what lies ahead in the

@Mubadala What excites @Mubadala about the booming Cell & Gene Therapy space? Ayman shares his thoughts on the enabling infrastructure that will shape the next generation of CGT innovations. Catch the full discussion!.

@Mubadala What happens when cutting-edge quantum tech collides with biotech? Alaa from @Mubadala Ventures shares insights into this exciting frontier and what the future holds for #QuantumBiotech. Don’t miss it!.